Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Low-dose Dexmedetomidine to Prevent Delirium in Liver Transplant Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02245256
Recruitment Status : Recruiting
First Posted : September 19, 2014
Last Update Posted : January 25, 2018
Sponsor:
Collaborator:
Hospira, now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
Ho Geol Ryu, Seoul National University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Actual Primary Completion Date : January 2018
  Estimated Study Completion Date : April 2018